Wakayama Medical University · Unclassified · 准教授

Research keywords乳癌・トリプルネガティブ乳癌・メチオニン制限・PARP阻害剤・エクソソーム

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Immunohistochemical Evaluation of Tumor Characteristic Retention in Triple-negative Breast Cancer PDOX Models.2025 · Anticancer research 45(10) 4169-4180 2025年10月
• Efficacy of Methionine Restriction and the PARP-inhibitor Olaparib and Their Combination on BRCA1 Mutant and Wild-type Triple-negative Breast Cancer Cell Lines.2025 · Anticancer research
• Efficacy of Methionine Restriction and the PARP-inhibitor Olaparib and Their Combination on BRCA1 Mutant and Wild-type Triple-negative Breast Cancer Cell Lines.2025 · Anticancer research 45(4) 1367-1372 2025年4月
• Induction of the DNA-Repair Gene POLQ only in BRCA1-mutant Breast-Cancer Cells by Methionine Restriction.2024 · Cancer genomics & proteomics 21(4) 399-404 2024年

• 涙液を用いた新しい乳癌早期診断法の確立2021
• がん早期診断における涙液エクソソームの有用性の検討2021 · 科学研究費助成事業
• がん早期診断における涙液エクソソームの有用性の検討2021
• 婦人科がん関連線維芽細胞サブセットの悪性誘発メカニズムの解明2021 · 科学研究費助成事業

• Official profile